SCHEMBL23926540

SCHEMBL23926540

CS(=O)(=O)[O-].CS(=O)(=O)[O-].[Cr+2]

nearest known ligand 0.50

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
CYP3A4 P08684 1/20 0.50
CA1 P00915 1/20 0.42
TSHR P16473 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
USP2 O75604 1/20 0.36
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350805 0.89 KDM4E (0.50) KDM4ECYP3A4CA1TSHRMEN1
SCHEMBL676774 0.89 KDM4E (0.50) KDM4ECYP3A4CA1TSHRMEN1
SCHEMBL17065543 0.89 KDM4E (0.50) KDM4ECYP3A4CA1TSHRMEN1
SCHEMBL23567016 0.89 KDM4E (0.50) KDM4ECYP3A4CA1TSHRMEN1
SCHEMBL20570026 0.89 KDM4E (0.50) KDM4ECYP3A4CA1TSHRMEN1
SCHEMBL22749162 0.89 KDM4E (0.50) KDM4ECYP3A4CA1TSHRMEN1
SCHEMBL22581617 0.89 KDM4E (0.50) KDM4ECYP3A4CA1TSHRMEN1
SCHEMBL20570539 0.89
SCHEMBL20570963 0.89 KDM4E (0.50) KDM4ECYP3A4CA1TSHRMEN1
SCHEMBL4352039 0.89 KDM4E (0.50) KDM4ECYP3A4CA1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230160083-A1 ELECTROLYTE AND METHOD FOR PRODUCING CHROMIUM LAYERS MASCHINENFABRIK KASPAR WALTER GMBH & CO. KG (DE) 2023-05-25 US claimed
EP-3899106-A1 ELECTROLYTE AND METHOD FOR PRODUCING CHROMIUM LAYERS Maschinenfabrik Kaspar Walter GmbH & Co. KG (DE) 2021-10-27 EP claimed
US-20260022489-A1 METHOD FOR CONTROLLING THE CHROMIUM FEED IN AN ELECTROLYSIS PROCESS FOR PRODUCING CHROMIUM LAYERS, AND AN ELECTROLYSIS CELL FOR THIS PURPOSE MASCHF KASPAR WALTER GMBH & CO KG (DE) 2026-01-22 US disclosed
EP-4577688-A1 METHOD FOR CONTROLLING THE CHROMIUM FEED IN AN ELECTROLYSIS PROCESS FOR PRODUCING CHROMIUM LAYERS, AND AN ELECTROLYSIS CELL FOR THIS PURPOSE Maschinenfabrik Kaspar Walter GmbH & Co. KG (DE) 2025-07-02 EP disclosed
WO-2024041968-A1 METHOD FOR CONTROLLING THE CHROMIUM FEED IN AN ELECTROLYSIS PROCESS FOR PRODUCING CHROMIUM LAYERS, AND AN ELECTROLYSIS CELL FOR THIS PURPOSE MASCHINENFABRIK KASPAR WALTER GMBH & CO. KG (DE) 2024-02-29 WO disclosed
US-20230160083-A1 ELECTROLYTE AND METHOD FOR PRODUCING CHROMIUM LAYERS MASCHINENFABRIK KASPAR WALTER GMBH & CO. KG (DE) 2023-05-25 US disclosed
EP-3899106-A1 ELECTROLYTE AND METHOD FOR PRODUCING CHROMIUM LAYERS Maschinenfabrik Kaspar Walter GmbH & Co. KG (DE) 2021-10-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022489-A1 METHOD FOR CONTROLLING THE CHROMIUM FEED IN AN ELECTROLYSIS PROCESS FOR PRODUCING CHROMIUM LAYERS, AND AN ELECTROLYSIS CELL FOR THIS PURPOSE CROCC, CA3, CA1 KDM4E 1186/4885CYP3A4 2639/4885CA1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.